Welcome to the Centre for Health Economics & Medicines Evaluation (CHEME). Founded in 2001, we are now one of the leading health economics centres in the UK. CHEME contributed to the University's UoA3 (subjects allied to health) submission to the 2021 Research Excellence Framework, which indicated that 95% of our research is internationally-excellent or world-leading, and which placed us 9th out of 89 institutions in terms of 3* and 4* outputs.

At CHEME, we aim to promote and sustain high-quality research, maximise opportunities for research grant capture and publications in high impact journals.

The Centre is active across a range of health economic and medicines evaluation research activities. These are broadly categorised into the following research themes:

  • Public health economics and the health economics of psychosocial interventions and other non-pharmacological health technologies, led by Professor Rhiannon Tudor Edwards
  • Pharmacoeconomics, pharmaceutical policy and medicines use, led by Professor Dyfrig Hughes

CHEME is a core part of the Bangor Institute of Health and Medical Research (BIHMR).